A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression

Condition:   TeratomaInterventions:   Drug: LEE011;   Drug: LEE011 PlaceboSponsor:   Novartis PharmaceuticalsNot yet recruiting - verified November 2014

Source: ClinicalTrials.gov - July 15, 2014 Category: Research Source Type: clinical trials